Pharma Cos. Launch 2nd Gout Antitrust Case Against Takeda
By Katie Buehler ( April 11, 2023, 7:08 PM EDT) -- A group of pharmaceutical companies has accused Takeda Pharmaceuticals and several other drug manufacturers of entering into anti-competitive deals related to the gout drug Colcrys, launching the second federal lawsuit in Pennsylvania that claims the deals were meant to postpone the development of a generic market for the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.